Product Images Cyclobenzaprine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 50090-3253 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Image - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01

Image - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01

IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02

IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02

This is a chart displaying the percentage of patients experiencing certain side effects from two different doses of the drug Cyclobenzaprine HCI Tablets and a placebo. The side effects are drowsiness, dry mouth, fatigue, and headache. The 5mg dosage had a total of 464 patients, and the 10mg dosage had a total of 249 patients. The placebo had a total of 469 patients.*

IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03

IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03

This text appears to be presenting data on the side effects associated with a medication called Cyclobenzaprine HCI Tablets, 10mg based on clinical studies and surveillance programs. It indicates that drowsiness is the most commonly reported side effect at 39%, followed by dry mouth at 2% and dizziness at 1%. The percentages in the surveillance program category are not clear as to what they represent.*

Label Image - lbl500903253

Label Image - lbl500903253

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.